| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/28/1986 | WO1986004783A1 Neovascularization inhibitors and methods for their production and use |
| 08/27/1986 | EP0192629A2 Method of somatotropin solubilization and naturation |
| 08/27/1986 | EP0192492A2 Peptides containing an aliphatic-aromatic ketone side chain |
| 08/27/1986 | EP0192393A2 Alkylaminofuranone derivatives |
| 08/27/1986 | EP0192392A2 Insulin receptor, its purification, its production in recombinant cells, DNA therefor, antibodies to insulin receptor and their preparation, and pharmaceutical compositions containing them |
| 08/27/1986 | EP0192360A1 Improvements in or relating to a method for increasing the feed intake of an animal |
| 08/27/1986 | EP0192002A1 Prolonged acting immunotoxins comprising a ribosome inactivating glycopeptide constituent having modified polyssaccharide moieties |
| 08/27/1986 | EP0191989A1 Antibiotic isoxazole derivatives, their production and use |
| 08/27/1986 | EP0191869A1 Fish calcitonin derivative, process for its preparation, and gene system therefor |
| 08/27/1986 | EP0191854A1 Antiviral peptides |
| 08/27/1986 | EP0191843A1 Modified tissue plasminogen activators |
| 08/27/1986 | EP0191804A1 Angiogenic factor and method for producing angiogenesis |
| 08/27/1986 | EP0191771A1 Automatic injector assembly. |
| 08/26/1986 | US4608365 Treatment of neurologic functions |
| 08/26/1986 | US4608364 Pharmaceutical agent for the treatment of diabetes mellitus |
| 08/26/1986 | US4608254 Method for the production of therapeutically administrable plasma derivatives filled in final containers |
| 08/26/1986 | US4608199 Bone protein purification process |
| 08/26/1986 | CA1210329A1 Production of purified porcine immunoglobulins |
| 08/20/1986 | EP0191606A2 Vectors and methods for expression of human protein C activity |
| 08/20/1986 | EP0191056A1 t-PA COMPOSITION AND METHOD OF GETTING INTO BLOOD STREAM |
| 08/20/1986 | CN86100915A Method of somatotropin solubilization and naturation |
| 08/19/1986 | US4607023 Natriuretic |
| 08/19/1986 | US4606917 Synergistic antiviral composition |
| 08/19/1986 | US4606857 Muramyldipeptide derivatives |
| 08/19/1986 | CA1209993A1 Condensed, seven-membered ring compounds and their use |
| 08/19/1986 | CA1209984A1 Keratinic derivative, preparation process and treatment composition containing said derivative |
| 08/19/1986 | CA1209940A1 Purified plasminogen activator, process for its production and thrombolytic composition containing it |
| 08/19/1986 | CA1209939A1 Process and device to encapsulate in erythrocytes at least one substance having a biological activity, particularly allosteric effectors of hemoglobin and erythrocytes thus obtained |
| 08/19/1986 | CA1209906A1 Pharmaceutical composition suitable for intestinal administration |
| 08/14/1986 | WO1986004608A1 Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same |
| 08/14/1986 | WO1986004607A1 Recombinant colony stimulating factor-1 |
| 08/14/1986 | WO1986004606A1 Cysteine-depleted muteins of biologically active human tumor necrosis factor proteins |
| 08/14/1986 | WO1986004605A1 Human granulocyte colony stimulating factor |
| 08/14/1986 | WO1986004589A1 Fsh |
| 08/14/1986 | WO1986004587A1 Purification of native colony stimulating factor-1 |
| 08/14/1986 | WO1986004580A1 Piperidine derivatives |
| 08/14/1986 | WO1986004506A1 Infection-protective agent containing human granulocyte colony-stimulating factor as effective ingredient |
| 08/14/1986 | WO1986004486A1 Method for purifying antihemophilic factor |
| 08/14/1986 | WO1986003751A3 Purification, production and use of tumor necrosis factors |
| 08/13/1986 | EP0190946A2 Novel cyclic hexapeptide LHRH antagonists |
| 08/13/1986 | EP0190852A2 Dipeptide derivatives and antihypertensive drugs containing them |
| 08/13/1986 | EP0190736A2 Chemical derivatives of GHL-Cu |
| 08/13/1986 | EP0190686A2 Method of producing interferon-gamma |
| 08/13/1986 | EP0190652A1 Genes for biologically active proteins |
| 08/13/1986 | EP0190597A2 Retro-inverso analogs of the bradykinin potentiating peptide bpp 5a |
| 08/13/1986 | EP0190464A2 Novel anti-cancer drugs |
| 08/13/1986 | EP0190254A1 Cloned gene and method for making and using the same |
| 08/13/1986 | EP0190199A1 Apparatus and methodology for pulsed administration of growth promoting agents |
| 08/13/1986 | EP0190185A1 Monoclonal antibodies and their use |
| 08/13/1986 | EP0190163A1 Growth-related hormone |
| 08/13/1986 | EP0190127A1 Immunotherapeutic polypeptide agents |
| 08/12/1986 | US4605643 Ovine GRF |
| 08/12/1986 | US4605642 Corticotropin releasing factor; antisecretory agents |
| 08/12/1986 | US4605641 Synthetic vasoactive intestinal peptide analogs |
| 08/12/1986 | US4605556 Applying interferon, polyhydric sugar alcohol, and organic acid buffer |
| 08/12/1986 | US4605555 Interferon, polyhydric sugar alcohol, organic acid buffer |
| 08/12/1986 | US4605515 Calcitonin-(1-23)-peptide amide |
| 08/12/1986 | US4605514 Des-4-leucine-calcitonin |
| 08/12/1986 | US4604968 Injection with thyroid compound |
| 08/12/1986 | CA1209473A1 Stable interferon b-composition and a method of stabilizing interferon b |
| 08/12/1986 | CA1209472A1 Anti-cancer drugs for the treatment of leukaemias t constituted by the chain a of ricin and a specific monoclonal antibody |
| 08/06/1986 | EP0190099A2 Polypeptide factors from colostrum |
| 08/06/1986 | EP0190058A1 Peptide derivatives with a polycyclic nitrogen structure, process for their preparation and pharmaceutical compositions containing them |
| 08/06/1986 | EP0190048A2 Bursopoietin |
| 08/06/1986 | EP0190041A2 Stabilized plasminogen activator precursor and method of producing the same |
| 08/06/1986 | EP0190018A2 Use of transforming growth factor to promote wound healing and composition therefor |
| 08/06/1986 | EP0189998A1 A process for preparing glucagon or derivatives thereof in a transformed yeast strain |
| 08/06/1986 | EP0189849A2 Method for treatment of neuroectodermal malignancies and epithelial carcinomas in humans |
| 08/06/1986 | EP0189841A2 Enzymatic detection of bacterial capsular polysaccharide antigens |
| 08/06/1986 | EP0189784A1 Human natural inhibitor of collagenases |
| 08/06/1986 | EP0189688A2 Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis |
| 08/06/1986 | EP0189673A1 Stable growth hormone releasing factor preparation |
| 08/06/1986 | EP0189587A2 Method of sterilizing recombinant microorganism |
| 08/06/1986 | EP0189485A1 Hexapeptide |
| 08/06/1986 | EP0189481A1 Insulin-like Growth factor II. |
| 08/06/1986 | EP0189451A1 Monoclonal antibodies and their use |
| 08/06/1986 | EP0189450A1 Monoclonal antibodies and their use |
| 08/05/1986 | US4604379 Dialysis solutions containing cross-linked gelatin |
| 08/05/1986 | US4604378 Basic V1 -vasopressin antagonists |
| 08/05/1986 | US4604376 Enteric compounds and complexes |
| 08/05/1986 | US4604359 Microbial expression of a gene for human growth hormone |
| 08/05/1986 | US4604285 Protein C enzyme derivatives |
| 08/05/1986 | US4604284 Homogeneous immune interferon fragment |
| 08/05/1986 | US4604238 Analogs of calcitonin |
| 08/05/1986 | US4604237 Des-21-threonine-calcitonin |
| 08/05/1986 | US4604236 Calcitonin analogs |
| 08/05/1986 | US4604234 Wound healing agents, dna promoter |
| 08/05/1986 | CA1209127A1 Protein derivative with remnants absorbing the uv rays attached to it, preparation process and compositions containing said derivative |
| 08/05/1986 | CA1209045A1 Lhrh preparations for intranasal administration |
| 08/05/1986 | CA1209038A1 Crystalline human leukocyte interferon |
| 08/05/1986 | CA1209037A1 Medicament comprising the product of the reaction of a c.sub.1 to c.sub.6 carboxylic acid on a basic amino acid |
| 07/31/1986 | WO1986004336A1 Monoclonal antibodies against core proteins of lymphadenopathy-associated-viruses |
| 07/31/1986 | WO1986004334A1 Immunoregulatory peptides |
| 07/31/1986 | WO1986004241A1 Immunotherapeutic methods and compositions employing antigenes characteristic of malignant neoplasms |
| 07/31/1986 | WO1986004240A1 Plasma substitute |
| 07/31/1986 | WO1986004239A1 Brain derivable polypeptide factors and antibodies |
| 07/31/1986 | WO1986004217A2 Protein hydrolysates, production process and drugs containing th em |
| 07/31/1986 | WO1986003495A3 Derivatives of substances p and of fragments thereof |
| 07/30/1986 | EP0189326A2 Derivatives of arginine vasopressin antagonists |
| 07/30/1986 | EP0189305A2 Peptide derivatives |